Skip to main content
Fig. 1 | Genome Biology

Fig. 1

From: The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation

Fig. 1

SERBP1 expression and impact on glioma survival and therapy. a SERBP1 mRNA expression in normal human tissue based on the GTEx database. b Comparative analysis of SERBP1 mRNA expression in normal brain/cortex (GTEx) and glioma samples (grades II, III, and IV) from the TCGA consortium. c Immunostaining of representative glioma samples (grades II, III, and IV) from the Shanghai Hospital cohort showing SERBP1 protein expression levels. d Kaplan–Meier curves indicate the survival of 177 glioma patients from the Shanghai Changzheng Hospital cohort displaying low and high SERBP1 levels. eg Kaplan-Meier curves indicate the survival of 118 GBM patients from the Shanghai Changzheng Hospital cohort displaying low and high SERBP1 levels: E (all patients), F (54 patients who received TMZ), and G (83 patients who received radiation)

Back to article page